MBot. Please check AKP history of capital raises. You will note this has never been an issue in the past so why would you think anything has changed now they have a developed product, totally commercialised and production ready. I have little doubt the chair and or his business partners will continue to provide the necessary funding to see AKP through to positive cash flow. I expect minimum dilution form the process as has historically been the case. $90m R&D to this point and 30m shares on issue says it all.
AKP Price at posting:
$19.70 Sentiment: Buy Disclosure: Held